Related Experiment Video
Updated: Jun 16, 2025

09:36
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
9.9K
Modeling Alzheimer's disease using human cell derived brain organoids and 3D models
Sarah Fernandes1,2, Jasmin Revanna1,2, Joshua Pratt1,3
1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, United States.
Frontiers in Neuroscience
|August 19, 2024
Summary
Brain organoids offer a promising model for studying Alzheimer's disease (AD) by mimicking human brain development and pathology. This review explores their use in understanding AD and related neurodegenerative diseases.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Pathology
Background:
- Age-related neurodegenerative diseases, such as Alzheimer's disease (AD), present significant challenges due to a lack of cures and limited treatments.
- A scarcity of functional, human-derived brain tissues with diverse genetic backgrounds and cellular subtypes hinders sporadic AD (sAD) research.
- Human stem cell-derived brain organoids show potential in modeling human brain cytoarchitecture and AD-like pathology.
Purpose of the Study:
- To review current strategies for utilizing brain organoids in Alzheimer's disease research.
- To discuss the challenges of using organoid models for studying age-related brain diseases.
Main Methods:
- Review of existing literature on brain organoid applications in AD research.
- Analysis of the capabilities and limitations of organoid models for neurodegenerative disease studies.
Main Results:
- Brain organoids can recapitulate aspects of human brain development and AD pathology.
- Organoids provide a valuable tool for investigating the link between AD pathology and neural cell dysfunction.
- Challenges remain in fully replicating the complexity of the aging human brain and sAD in organoid systems.
Conclusions:
- Brain organoids are an emerging and valuable tool for advancing Alzheimer's disease research.
- Further development is needed to overcome challenges in modeling complex age-related neurological disorders.
Keywords:
APOEAlzheimer’s diseaseagingamyloid betabrain organoidscerebral organoidshyperphosphorylated tauneurodegenerative diseases
